“Association of Tumor Mutation Burden and Epidermal Growth Factor Receptor Inhibitor History With Survival in Patients With Metastatic Stage III IV Nonsmall-Cell Lung Cancer: A Retrospective Study”. Clinics 76 (November 9, 2021): e2251. Accessed June 17, 2024. https://journals.usp.br/clinics/article/view/192286.